NFID Launches New Spanish Website for Disease Prevention and Treatment
New Spanish Website Aims to Educate and Empower Patients, Caregivers, and Healthcare Professionals to Make Informed Health Decisions BETHESDA, Md.,...
News
New Perspective Senior Living Expands LifeLoop Partnership to Innovate the Resident Experience
Premier senior living operator partners with LifeLoop to scale community operations, empower staff, and enrich resident life across its 40-community...
InteliChart Rated Top Patient Engagement Platform for Second Consecutive Year by Black Book Research
Nationwide poll of over 5,000 healthcare professionals recognized the company for its outstanding client satisfaction and best of breed technology....
Epigenica Unveils Breakthrough Epigenetics Platform, Launches First Commercial ChIP-seq Kit for High-throughput, Multiplex Genome-wide Profiling
EpiFinder™ Platform generates quantitative data at scale, with unprecedented speed and cost-efficiencyEpiFinder Genome generates 192 genome-wide profiles by simultaneously targeting up...
First Stop Health Named in Inc. Magazine’s 2024 List of Best Workplaces
For a third consecutive year, virtual care company makes the list of Best Workplaces with "caring" at its core.CHICAGO, IL...
Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent
CHICAGO, IL / ACCESSWIRE / June 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Angle PLC Announces Posting of 2023 Annual Report & Notice of the AGM
GUILDFORD, SURREY / ACCESSWIRE / June 18, 2024 / ANGLE plc ("the Company") (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with...
CLS Health Launches New Multi-Specialty Building, Expanding Healthcare Access in Clear Lake
CLEAR LAKE, TX / ACCESSWIRE / June 18, 2024 / CLS Health, a leader in comprehensive healthcare, proudly announces the...
Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be...
LivaNova to Announce Second-Quarter 2024 Results
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024...
Bemax Inc. Announces Pre-Orders on Walmart for the Newly Designed Private Label Brand
Dallas, Georgia--(Newsfile Corp. - June 18, 2024) - Bemax Inc. (OTC Pink: BMXC), a private label development company with a...
Dr. Malik Kutty of Luxe Plastic Surgery Appears on Fox 26 Houston to Discuss Fillers
SUGAR LAND, TX / ACCESSWIRE / June 18, 2024 / Getting fillers is incredibly common, but as Dr. Malik Kutty,...
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Partnership Will Aid Physicians in Precision Prescribing Decisions Based on Applied DNA's TR8™ Pharmacogenomic (PGx) Test STONY BROOK, NY /...
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debtInterest...
Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically
TORONTO, ON / ACCESSWIRE / June 18, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
AllStar Health Brands Inc (OTC:ALST) Targets Italy Level 2 Soccer Club in Italy
All Star Health Brands has hired MergersCorp Investment Banking for a Soccer AcquisitionNEW YORK, NY / ACCESSWIRE / June 18,...
Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers
Day One receives exclusive license for development and commercialization of MTX-13 (DAY301), which received IND clearance by the FDA in...
Elicio Therapeutics Reports Inducement Grants
BOSTON, June 18, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company...
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
Pharmacokinetic study is key step on path to expansion into US marketNEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent...
Prenetics Announces First Quarter 2024 Financial Results
First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S....